Dr James Brown

Two weeks left to apply to be the BSCB Postdoc rep

Happy New Year from the BSCB! We're very excited to announce 'BSCB NextGen', a new monthly online seminar series aimed at ECRs in Cell Biology.

The series kicks off on 13th January

For full details and how to register see:
bscb.org/announcing-b...

In a recent article with The Conversation, Dr @dr-jamesbrown.bsky.social , member of the LDCRC leadership team, shares how patient voices challenge researchers to think differently and ensure real-world impact through PPI Limerick Cancer Research.

Delighted to have this finally to highlight all the essential work done by PPI contributing to research.
@ldcrc-ul.bsky.social
@hri-ul.bsky.social @unioflimerick.bsky.social
@aicri.bsky.social

The Biochemical Society 2027 Awards Do you know someone who deserves recognition for their contribution to the molecular biosciences? Nominations can be submitted by both members and non-members Deadline 3 November 2025

Last chance to submit your nominations for 2027 Awards! Categories available for individuals, teams & organisations across all areas of the molecular biosciences, don't miss the chance to shine a light on leaders in your field. Deadline: midnight tonight! 🧪 buff.ly/rBWlssp

I would think that more effective treatments (used on groups of patients that have been profiled to know it will work on them, or used in improved settings like neoadjuvant) will ultimately create long-term savings and improve cost-effectiveness- but we need more studies to confirm.

Thank you, it really highlights that not only is neoadjuvant treatment clinically effective, it is also increasingly cost effective. It also highlights the growing cost of treating older patients, an important consideration for healthcare systems with (worldwide) aging populations.

Healthcare costs and health outcomes analysis of Neoadjuvant Trastuzumab therapy for HER2 positive breast cancer. Globally, the incidence of breast cancer continues to rise; however, mortality rates are declining due to the growing effectiveness of targeted therap…

Delighted to announce our latest publication is out!

Healthcare costs and health outcomes analysis of Neoadjuvant Trastuzumab therapy for HER2 positive breast cancer.

www.sciencedirect.com/science/arti...

Workshop Decoding Whole Genome Doubling: Insights From Evolution, Development and Disease Organisers: Renata Basto and Zuzana Storchova Early-career researchers apply for funded places The Company of Biologists logo to the left 2-5 November 2025 Fanhams Hall, Hertfordshire, UK

One month left for early-career researchers to apply for a funded place at our Workshop 'Decoding whole genome doubling: Insights from evolution, development and disease' organised by Renata Basto and Zuzana Storchova. biologists.com/workshops/de... #BiologistsWorkshops

If you're attending #biologists100 visit our exhibition stand & chat to our PhD reps @harrietasmith.bsky.social @emilyxlucas.bsky.social

They're looking for volunteers to film a 60 sec video discussing your work or poster

You'll get one of our lovely BSCB mugs!

Only one week to go until #biologists100 conference!

Check out this pre-conference guide from @biologists.bsky.social @the-node.bsky.social @focalplane.bsky.social @prelights.bsky.social